News

J&J’s new pivotal study in coronary artery disease, dubbed FORWARD CAD, will test a cardiac-focused version of the Javelin as ...
While the symptoms and signs of coronary artery disease are noted in the advanced ... and (along with the activation of the blood clotting system) start limiting blood flow to the heart muscle.
An insurance dispute between Blue Cross and Blue Shield and 2 hospital systems led to days of confusion for patients.
For decades, the clinical approach to coronary artery disease has been centred on the acute effects of coronary occlusion and ...
Having a coronary artery calcium (CAC) score of zero has generally been accepted as a marker of a very low risk of having a ...
For decades, the management of coronary artery disease has focused on epicardial obstruction and ischaemia, which is often recognised too late for long-term intervention. This approach limits the ...
Researchers from Philadelphia-based University of Pennsylvania’s Leonard Davis Institute of Health Economics recently found ...
Medical Device Network on MSN13h
Elixir Medical debuts IVL system in Europe
Elixir trails J&J’s Shockwave but has outpaced Bolt Medical to the European market with its mechanical IVL system.
GE HealthCare’s Revolution Vibe is an ‘all-in-one’ system aimed at boosting the accessibility of CT angiography (CCTA).
A significant percentage of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) demonstrate coronary artery calcification (CAC) on imaging, with variations by ANCA ...